TrianglePUBLICATIONS · 22184397
Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2012 Jan 20
- First author
- Malempati S
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Malempati S
- type
- Author
- name
- Weigel B
- type
- Author
- name
- Ingle AM
- type
- Author
- name
- Ahern CH
- type
- Author
- name
- Carroll JM
- type
- Author
- name
- Roberts CT
- type
- Author
- name
- Reid JM
- type
- Author
- name
- Schmechel S
- type
- Author
- name
- Voss SD
- type
- Author
- name
- Cho SY
- type
- Author
- name
- Chen HX
- type
- Author
- name
- Krailo MD
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Malempati S
- type
- Author
- name
- Weigel B
- type
- Author
- name
- Ingle AM
- type
- Author
- name
- Ahern CH
- type
- Author
- name
- Carroll JM
- type
- Author
- name
- Roberts CT
- type
- Author
- name
- Reid JM
- type
- Author
- name
- Schmechel S
- type
- Author
- name
- Voss SD
- type
- Author
- name
- Cho SY
- type
- Author
- name
- Chen HX
- type
- Author
- name
- Krailo MD
- type
- Author
- bibliography ids
- nci-bib-72b95e12d33ff48e8ee99cb1
- book metadata
- content sha256
- 5dc3bf14582e3765b151e62d627b0e5366c40e9b582c045fd10fe5dda6d1b2ea
- document type
- citation
- dois
- 10.1200/JCO.2011.37.4355
- electronic publication date
- display
- 2011 Dec 19
- precision
- day
- year
- 2011
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:22184397
- immutable id
- pubmed:22184397@5dc3bf14582e3765b151e62d627b0e5366c40e9b582c045fd10fe5dda6d1b2ea
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 3
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 256-62
- volume
- 30
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 22184397
- provenance
- batch id
- b6284687e167e7da9556
- provider
- NCBI PubMed ESummary
- record sha256
- 22fdfab121c8c5ea87eab364eb4b33bc9b62283a76a7953559f97e18d8b8a8e5
- response sha256
- 64d5b7bb63f574c559af2523b779a262267cbc8e8cd02a5b47f4193cc95cabd3
- retrieved at
- 2026-09-09T23:46:45.216259+00:00
- publication date
- display
- 2012 Jan 20
- precision
- day
- year
- 2012
- publication types
- Clinical Trial, Phase I
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, N.I.H., Extramural
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group.
Preserved source evidence · Not medical advice